Arkolith/Insider Trading/OCEL/Form 4

Skycrest Holdings, LLC

10% OwnerOrganicell Regenerative Medicine, Inc. (OCEL) · full profile →Form 4 · filed Jun 30, 2023
Net Buying
Open-Market Buys
$6K
Open-Market Sells
$0
Net Open-Market Flow
$6K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2023Buy(P)200K$0.01$2K51.4M
Jun 28, 2023Buy(P)400K$0.01$4K51.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001829126-23-004522) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML